IRIDEX EPS - Earnings per Share 2010-2023 | IRIX
IRIDEX eps - earnings per share from 2010 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| IRIDEX Annual EPS |
| 2023 |
$-0.59 |
| 2022 |
$-0.47 |
| 2021 |
$-0.34 |
| 2020 |
$-0.46 |
| 2019 |
$-0.64 |
| 2018 |
$-1.05 |
| 2017 |
$-1.11 |
| 2016 |
$-1.15 |
| 2015 |
$0.05 |
| 2014 |
$0.97 |
| 2013 |
$0.22 |
| 2012 |
$0.16 |
| 2011 |
$0.26 |
| 2010 |
$0.30 |
| 2009 |
$0.26 |
| IRIDEX Quarterly EPS |
| 2023-12-31 |
$-0.18 |
| 2023-09-30 |
$-0.11 |
| 2023-06-30 |
$-0.17 |
| 2023-03-31 |
$-0.13 |
| 2022-12-31 |
$-0.07 |
| 2022-09-30 |
$-0.11 |
| 2022-06-30 |
$-0.14 |
| 2022-03-31 |
$-0.15 |
| 2021-12-31 |
$-0.15 |
| 2021-09-30 |
$-0.14 |
| 2021-06-30 |
$0.09 |
| 2021-03-31 |
$-0.14 |
| 2020-12-31 |
$-0.02 |
| 2020-09-30 |
$-0.12 |
| 2020-06-30 |
$-0.20 |
| 2020-03-31 |
$-0.12 |
| 2019-12-31 |
$-0.11 |
| 2019-09-30 |
$-0.13 |
| 2019-06-30 |
$-0.18 |
| 2019-03-31 |
$-0.22 |
| 2018-12-31 |
$-0.20 |
| 2018-09-30 |
$-0.26 |
| 2018-06-30 |
$-0.28 |
| 2018-03-31 |
$-0.31 |
| 2017-12-31 |
$-0.44 |
| 2017-09-30 |
$-0.27 |
| 2017-06-30 |
$-0.24 |
| 2017-03-31 |
$-0.16 |
| 2016-12-31 |
$-1.06 |
| 2016-09-30 |
$-0.07 |
| 2016-06-30 |
$-0.03 |
| 2016-03-31 |
$0.01 |
| 2015-12-31 |
$0.06 |
| 2015-09-30 |
$0.04 |
| 2015-06-30 |
$-0.07 |
| 2015-03-31 |
$0.02 |
| 2014-12-31 |
$0.84 |
| 2014-09-30 |
$0.05 |
| 2014-06-30 |
$0.03 |
| 2014-03-31 |
$0.05 |
| 2013-12-31 |
$0.04 |
| 2013-09-30 |
$0.05 |
| 2013-06-30 |
$0.04 |
| 2013-03-31 |
$0.09 |
| 2012-12-31 |
$0.03 |
| 2012-09-30 |
$-0.08 |
| 2012-06-30 |
$0.03 |
| 2012-03-31 |
$0.18 |
| 2011-12-31 |
$0.08 |
| 2011-09-30 |
$0.03 |
| 2011-06-30 |
$0.09 |
| 2011-03-31 |
$0.06 |
| 2010-12-31 |
$0.08 |
| 2010-09-30 |
$0.09 |
| 2010-06-30 |
$0.08 |
| 2010-03-31 |
$0.05 |
| 2009-12-31 |
$0.05 |
| 2009-09-30 |
$0.07 |
| 2009-06-30 |
$0.12 |
| 2009-03-31 |
$0.02 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.049B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
